Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
QuintilesIMS
Johnson and Johnson
Chinese Patent Office
Covington
Merck
Medtronic
Accenture

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,895,557

« Back to Dashboard

Which drugs does patent 8,895,557 protect, and when does it expire?

Patent 8,895,557 protects YONDELIS and is included in one NDA.

This patent has thirty-nine patent family members in thirty-five countries.
Summary for Patent: 8,895,557
Title:Pharmaceutical formulations of ecteinascidin compounds
Abstract: Ecteinascidin formulations, methods of preparing the same, articles of manufacture and kits with such formulations, and methods of treating proliferative diseases with the same formulations are provided.
Inventor(s): Beijnen; Jacob Hendrik (Amsterdam, NL), Nuijen; Bastiaan (Amsterdam, NL), Salve; Pilar Calvo (Madrid, ES), Barreira; Maria Tobio (Madrid, ES)
Assignee: Pharma Mar, S.A., Sociedad Unipersonal (Madrid, ES)
Application Number:11/261,876
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;

Drugs Protected by US Patent 8,895,557

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Janssen Prods YONDELIS trabectedin POWDER;IV (INFUSION) 207953-001 Oct 23, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,895,557

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation 2382647 ➤ Try a Free Trial
Russian Federation 2007119724 ➤ Try a Free Trial
Serbia 50510 ➤ Try a Free Trial
Portugal 1658848 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Medtronic
Accenture
Boehringer Ingelheim
Harvard Business School
Cerilliant
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.